Article
Structural, functional, and immunogenicity implications of F9 gene recoding
12 Apr 2022
Abstract excerpt
Hemophilia B is a blood clotting disorder caused by deficient activity of coagulation factor IX (FIX). Multiple recombinant FIX proteins are currently approved to treat hemophilia B, and several gene therapy products are currently being developed. Codon optimization is a frequently used technique in the pharmaceutical industry to improve recombinant protein expression by recoding a coding sequence using multiple...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
